Trump’s approach on China has changed, now appears focused on getting along

U.S.-China merchandise trade has fallen by more than one-third since Trump’s last Beijing visit eight years ago, underscoring a structural cooling in bilateral ties. The article says Trump’s China approach has shifted from trying to force changes in China’s state-led model to focusing on accommodation and selectively emulating Beijing’s business practices. The piece is more strategic and political than immediately market-moving, but it reinforces ongoing trade-policy and geopolitical uncertainty.

Analysis

The market implication is not simply “better relations” versus “worse relations”; it is a shift from structural decoupling toward managed interdependence. That reduces headline tariff risk premia in the near term, but it also entrenches a world where firms optimize around policy ambiguity rather than commit to clean supply-chain relocation. The biggest beneficiaries are likely to be companies with dual-source flexibility and pricing power, while the losers are firms that spent heavily to onshore capacity under the assumption that Washington would keep pushing hard for bifurcation.

Second-order effects matter more than the bilateral tone. If policy becomes less confrontational, cross-border goods flows may stabilize, but strategic competition likely migrates into less visible channels: export controls, outbound investment screening, industrial subsidies, and procurement rules. That tends to favor U.S. domestic champions in semis, defense, and critical infrastructure over pure import-dependent retailers and manufacturers, because the latter still face periodic shocks without the offsetting benefit of easier market access.

The contrarian read is that the market may be underestimating how much policy drift lowers volatility without improving growth. A softer posture can compress geopolitical risk premiums for months, but it does not fix margin pressure from fragmented supply chains, compliance costs, or episodic retaliation. In other words, the right trade is not to bet on a broad China rebound, but on relative winners that gain from lower tariff headline risk while remaining insulated if tensions re-accelerate.

Catalyst-wise, the key horizon is 3-12 months: watch for any escalation around export restrictions, Taiwan-related signaling, or election-season rhetoric that could quickly reprice the regime. If the administration continues leaning into selective accommodation, companies with China exposure but low policy sensitivity could rerate modestly; if not, the market will rediscover that ‘getting along’ is mostly tactical, not structural.

Key Decisions for Investors

• Overweight U.S. multinational industrials with diversified end markets and China revenue that is non-core to the investment case; use a 3-6 month horizon and prefer names with low single-digit China exposure so any easing in trade friction adds upside without thesis dependence.
• Pair long semicap equipment / critical-tech supply chain beneficiaries against short import-dependent discretionary or retail names; the setup favors firms that benefit from policy de-risking more than from trade normalization, with a 6-12 month horizon.
• Buy downside protection on U.S.-China headline risk via cheap 3-6 month index puts or put spreads on broad growth proxies during periods of complacency; the payoff is asymmetric if export-control rhetoric returns abruptly.
• Avoid chasing a broad China beta rally unless accompanied by concrete tariff rollbacks and export-control relief; absent that, treat any strength as tactical and trim into 10-15% moves.
• If looking for a relative-value expression, go long domestic-capacity beneficiaries and short companies whose margins depend on uninterrupted China inputs; the risk/reward improves if policy remains ambiguous rather than decisively hawkish.